AGP Executive Report
Last update: 2 hours agoHealth Watch: A new Canadian Journal of Ophthalmology study flags specific drugs tied to higher uveitis reports, with the strongest safety signals for cidofovir and rifabutin—raising fresh questions about medication side effects. Medical Tech: Next-gen premium cataract lenses are reshaping surgery choices, but the real challenge is matching the right lens to each patient’s lifestyle and budget. Pediatrics & Mental Health: A Canadian presentation argues multimodal care can better manage depression in children, noting far too few young people get professional help. Infectious Disease: Pfizer and Valneva say their Lyme vaccine candidate hit 73.2% efficacy in a phase 3 trial across the US, Canada and Europe, with results tied to the second tick season. Cybersecurity: Instructure says it reached an agreement after the Canvas breach, claiming stolen data was returned and destroyed. Climate: Scientists warn a strong El Niño could supercharge extreme weather and fires as 2026 heats up. Canada Tech/Policy: Apple and Meta are pushing back on Canada’s encryption/surveillance Bill C-22, warning it could weaken protections.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result.
Perspectify News
